Lifevantage (LFVN) closed at $4.77 on November 16, 2026, down 4.0% from the previous close, on volume of 118,118 shares (30-day average 35,659).
Data as of November 16, 2026.
16-Nov-2026
LifeVantage Earnings Call Highlights Reset and Recovery
TipRanks (Sat, 14-Nov 9:54 PM ET)
LifeVantage Stockholders Elect Directors and Approve Proposals
TipRanks (Thu, 12-Nov 4:54 PM ET)
LifeVantage Declares Quarterly Dividend
Globe Newswire (Mon, 9-Nov 4:06 PM ET)
LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
Globe Newswire (Mon, 9-Nov 4:05 PM ET)
Globe Newswire (Thu, 29-Oct 4:05 PM ET)
LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
Globe Newswire (Mon, 26-Oct 4:05 PM ET)
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Mon, 12-Oct 4:05 PM ET)
LFVN Highlights September 23 Virtual Conference Appearance With CEO and CFO Set to Present
Market Chameleon (Fri, 18-Sep 6:57 AM ET)
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
Globe Newswire (Fri, 18-Sep 8:00 AM ET)
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
Globe Newswire (Thu, 27-Aug 4:05 PM ET)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
Lifevantage trades on the NASDAQ stock market under the symbol LFVN.
As of November 16, 2026, LFVN stock price declined to $4.77 with 118,118 million shares trading.
LFVN has a beta of 0.55, meaning it tends to be less sensitive to market movements. LFVN has a correlation of 0.01 to the broad based SPY ETF.
LFVN has a market cap of $60.49 million. This is considered a Micro Cap stock.
Last quarter Lifevantage reported $37 million in Revenue and $.05 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.01.
In the last 3 years, LFVN traded as high as $27.38 and as low as $3.90.
The top ETF exchange traded funds that LFVN belongs to (by Net Assets): VTI, AVUV, VXF, DFAS, IWC.
LFVN has underperformed the market in the last year with a price return of -25.1% while the SPY ETF gained +11.3%. LFVN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.6% and -18.7%, respectively, while the SPY returned -4.4% and -1.6%, respectively.
LFVN support price is $4.73 and resistance is $5.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFVN shares will trade within this expected range on the day.